IFP Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-500
Closed -$13K 4272
2017
Q1
$13K Buy
+500
New +$10.2K ﹤0.01% 2790

IFP Advisors's FLXN Position: Q4 2021 in Review

IFP Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 56 shares — an estimated $1K sold.

IFP Advisors first reported a position in FLXN in Q3 2016 and held it in 11 quarters. The position peaked at $225K in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • IFP Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • IFP Advisors sold 56 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $1K.
  • IFP Advisors first reported a position in Flexion Therapeutics, Inc. in Q3 2016 and held it in 11 quarters.
  • IFP Advisors's Flexion Therapeutics, Inc. position peaked at $225K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.